Next Generation Sequencing (NGS) Services Market Worth 2,921.4 Million USD by 2023, Says Meticulous Research™


LONDON, March 21, 2018 (GLOBE NEWSWIRE) -- According to this latest publication from Meticulous Research™, NGS services market to reach USD 2,921.4 million by 2023, growing at a CAGR of 20.1% during the forecast period of 2018 to 2023. “Plummeting cost of sequencing, growing need of skilled professionals for efficient NGS sample preparation and analysis, technological advancements, increase in genome mapping programs, and high cost of sequencing infrastructure are the major factors driving the growth of NGS services market”, mentions Meticulous Research™.

The report also notes that, “growing application of NGS technology in cancer and agrigenomics research for the analysis of complex sequencing data and rising demand for personalized medicine provides significant opportunities to NGS service providers.”

Request Sample Report:

Geographically, North America dominated the global NGS services market in 2017, mainly due to the increasing burden of chronic and infectious diseases, growing R&D expenditure, various government initiatives, and the presence of many services providers in this region.

The key players in the global NGS services market are Illumina, Inc., Qiagen N.V., PerkinElmer, Inc., Eurofins Scientific SE, GATC Biotech AG, Macrogen, Inc., Genotypic Technology Pvt. Ltd., GENEWIZ, Inc., Beijing Genomics Institute, SciGenom Labs Pvt. Ltd., MedGenome, DNA Link, Inc., Otogenetics Corporation, Novogene Corporation, LGC Limited, CD Genomics, and SeqLL, LLC.

Full News:

Scope of the Report:

Market by Service Type:

  •  Targeted Sequencing
  •  RNA Sequencing
  •  Exome Sequencing
  •  De Novo Sequencing
  •  ChIP-Sequencing
  •  Whole Genome Sequencing
  •  Methyl Sequencing
  •  Other Services

Market by Technology:

  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor Sequencing (IOS)
  • Single Molecule Real Time Sequencing (SMRT)
  • Nanopore Sequencing
  • True Single Molecule Sequencing (tSMS)

Market by Application:

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Agriculture & Animal Research
  • Other Applications

Market by End User:

  • Academic & Research Institutes
  • Pharmaceuticals & Biotechnology Industry
  • Hospitals & Clinics
  • Other End Users

Market by Geography:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East & Africa

Browse in-depth report here:

Contact Info:

Viren Shrivastava
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)